Document:

EXHIBIT 10.6
                              WAIVER AND AMENDMENT
                              --------------------

     This WAIVER AND AMENDMENT ("Amendment") is made as of this 18th day of
December, 2008, by and between CDEX Inc., a Nevada corporation ("Company"), and
GEMINI MASTER FUND, LTD., a Cayman Islands company ("Holder").

                              W I T N E S S E T H:
                              --------------------

       WHEREAS, pursuant to that certain Securities Purchase Agreement
("Purchase Agreement") dated as of June 25, 2008 by and between the Company and
the Holder, on or about such date the Company sold and issued to the Holder (i)
a 12% Senior Convertible Note ("Note"), which Note is convertible into shares of
common stock of the Company, $0.005 par value per share ("Common Stock"), and
(ii) a Common Stock Purchase Warrant to purchase up to 2,717,391 shares of
Common Stock ("Warrant"); capitalized terms used herein but not otherwise
defined herein shall have the meanings set forth in the Purchase Agreement, the
Note or the Warrant, as the case may be; and

       WHEREAS, the Company wishes (a) to issue shares of Common Stock in one or
more financings between the date hereof and April 1, 2009 ("Waiver Period")
without the anti-dilution adjustments applying as set forth in the Transaction
Documents in certain circumstances, (b) to delay payments of the Monthly
Redemption Amount due on January 1, 2009 under the Note until February 1, 2009,
and (c) to allow for prepayment of the Note under certain conditions, and the
Holder desires to consent to such requests, on the terms and conditions set
forth herein;

       NOW THEREFORE, in consideration of the foregoing premises and the mutual
covenants set forth in this Amendment, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto agree as follows:

     1.   Subsequent Issuance Waivers
          ---------------------------

          (a) -Common Stock Issuances. Notwithstanding anything contained in the
     Transaction Documents, to the extent the Company sells and issues shares of
     Common Stock or warrants in one or more Common Stock Financings (as defined
     below) during the Waiver Period for gross proceeds which do not exceed
     $500,000 in the aggregate, such issuances shall constitute "Exempt
     Issuances" under the Transaction Documents. For purposes hereof, "Common
     Stock Financing" means the sale and issuance of shares of Common Stock by
     the Company in a capital raising financing, provided that (a) the effective
     sale price per share of Common Stock shall equal at least $0.10, (b) the
     transaction shall not be a Variable Rate Transaction or MFN Transaction,
     and (c) the Company may issue to the purchasers thereof, in connection with
     any such financing, warrants to purchase a number of shares of Common Stock
     equal to 50% of the number of shares of Common Stock sold to such
     purchasers in such financing, provided that the effective exercise price
     per share of Common Stock under such warrants shall equal at least $0.20.
     For clarification, a Common Stock Financing may result from the sale and
     issuance of shares of Common Stock pursuant to the exercise of currently

<PAGE>

     outstanding warrants following a reduction of the exercise price
     thereunder, provided that the provisions of the preceding sentence are
     satisfied. Notes issued subsequent to the Effective Date of the Transaction
     Documents to the CEO or entities controlled by the CEO or his family up to
     a combined gross principal amount of $135,000 on terms no more favorable
     than those contained in the Transaction Documents shall not count as a part
     of the $500,000.

     2. January Monthly Redemption. The Holder hereby agrees that the Company,
at its option, may delay payment of the Monthly Redemption Amount due on January
1, 2009 until February 1, 2009 (in which case on February 1, 2009 the Company
shall pay the Monthly Redemption Amount originally due for January 1, 2009 and
February 1, 2009, i.e., $169,555.29, consisting of $45,289.86 principal
repayment for each of January 1st and February 1st and $78,975.58 of interest).

     3. Prepayment. Notwithstanding anything contained in the Note, the Company
shall have the right to prepay the Note in cash, in whole or in part, at any
time during the Waiver Period for consideration equal to the principal amount
being prepaid plus all accrued and unpaid interest thereon, provided that (a)
the Company furnishes to the Holder written notice thereof at least ten (10)
Business Days prior to the date of any such prepayment, and (b) during such
notice period the Holder may convert such principal amount elected to be
prepaid. Such prepayment amount shall be payable in full on the date selected by
the Company (which must be during the Extended Wavier Period).

     4. Rule 144. The Company acknowledges and agrees that, for purposes of Rule
144 promulgated under the Securities Act of 1933, as amended ("Securities Act"),
the holding period for the shares of Common Stock issuable upon conversion or
cashless exercise of, or otherwise pursuant to, the Note and/or Warrant, shall
have commenced on June 25, 2008 (the date of original issuance of the Note and
the Warrant), notwithstanding this Amendment. Without limiting the foregoing, if
at any time it is determined that such holding period does not relate back to
such date, the Company will promptly cause the registration of all such
underlying shares under the Securities Act (without regard to any beneficial
ownership or issuance limitations contained in the Note and/or Warrant). In
connection with any registration of shares of Common Stock pursuant to this
Section, the Company and the Holder shall enter into a registration rights
agreement containing customary and reasonable provisions regarding the
registration of securities under the Securities Act.

     5. Disclosure. To the extent the transactions contemplated by this
Amendment constitute material non-public information concerning the Company or
are otherwise required to be publicly disclosed under the Securities Exchange
Act of 1934, as amended, and the rules promulgated thereunder, the Company
shall, within three (3) business days following the date hereof, issue a press
release and/or Current Report on Form 8-K disclosing the material terms of the
transactions contemplated hereby. The Company and the Holder shall consult with
each other in issuing any other press releases with respect to the transactions
contemplated hereby.

<PAGE>

     6. Miscellaneous.
        --------------

          (a) Full Force and Effect. Except as otherwise expressly provided
     herein, each of the Purchase Agreement, the Note, the Warrant and the other
     agreements and transactions contemplated thereby ("Transaction Documents")
     shall remain in full force and effect. Except for the waiver and
     modifications contained herein, this Amendment shall not in any way waive
     or prejudice any of the rights or obligations of the Holder or the Company
     under the Transaction Documents, under any law, in equity or otherwise, and
     such modifications shall not constitute a waiver or modification of any
     other provision of the Transaction Documents nor a waiver or modification
     of any subsequent default or breach of any obligation of the Company or of
     any subsequent right of the Holder.

          (b) Governing Law. This Amendment shall be governed by and construed
     in accordance with the internal laws of the State of New York.

          (c) Counterparts. This Amendment may be executed in any number of
     counterparts, each of which will be deemed an original, but all of which
     together will constitute one and the same instrument. This Amendment may be
     executed by facsimile or by email of a digital image format or portable
     document format of the signature page hereto.

     IN WITNESS WHEREOF, each of the parties hereto has caused this Amendment to
be duly executed effective the date first written above.

                                         CDEX INC.

                                         By:
                                         Name:  Malcolm H. Philips, Jr.
                                         Title: CEO

                                         GEMINI MASTER FUND, LTD.
                                         By:    GEMINI STRATEGIES, LLC,
                                                as investment manager

                                         By: _______________________________
                                         Name:  Steven Winters
                                         Title: PresidentEXHIBIT 10.7
                           SECOND WAIVER AND AMENDMENT
                           ---------------------------

     This SECOND WAIVER AND AMENDMENT ("Amendment") is made effective this 1st
day of February, 2009, by and between CDEX Inc., a Nevada corporation
("Company"), and GEMINI MASTER FUND, LTD., a Cayman Islands company ("Holder").

                              W I T N E S S E T H:
                              --------------------

       WHEREAS, pursuant to that certain Securities Purchase Agreement
("Purchase Agreement") dated as of June 25, 2008 by and between the Company and
the Holder, on or about such date the Company sold and issued to the Holder (i)
a 12% Senior Convertible Note ("Note"), which Note is convertible into shares of
common stock of the Company, $0.005 par value per share ("Common Stock"), and
(ii) a Common Stock Purchase Warrant to purchase up to 2,717,391 shares of
Common Stock ("Warrant");

       WHEREAS, by agreement dated December 18, 2008 entitled Waiver and
Amendment ("First Amendment") the Transaction Documents were amended;
capitalized terms used herein but not otherwise defined herein shall have the
meanings set forth in the Purchase Agreement, the Note, the Warrant, or the
First Amendment, as the case may be: and

       WHEREAS, the Company wishes (a) to sell shares of Common Stock in
addition to such Stock sold in relation to Section 1 of the First Amendment in
one or more financings between the date hereof and May 1, 2009 ("Extended Waiver
Period") without the anti-dilution adjustments applying as set forth in the
Transaction Documents in certain circumstances, (b) to delay payments to Holder
for interest and Monthly Redemption Amounts due on February 1, March 1 and April
1, 2009 under the Note until May 1, 2009, and (c) to allow for prepayment of the
Note under certain conditions, and the Holder desires to consent to such
requests, on the terms and conditions set forth herein;

       NOW THEREFORE, in consideration of the foregoing premises and the mutual
covenants set forth in this Amendment, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto agree as follows:

     1. Subsequent Issuance Waivers--Common Stock Issuances. Notwithstanding
anything contained in the Transaction Documents, including the First Amendment,
to the extent the Company sells and issues shares of Common Stock or warrants in
one or more Common Stock Financings (as defined below) during the Extended
Waiver Period for gross proceeds in excess of the $500,000 addressed in Section
1 of the First Amendment, such issuances shall constitute "Exempt Issuances"
under the Transaction Documents, provided that the Company hereby agrees that at
least 50% of all funds so raised shall be sent to Holder within fifteen (15)
days of receipt of funds as payment of principal and interest owed to Holder
pursuant to the Transaction Documents. For purposes hereof, "Common Stock
Financing" means the sale and issuance of shares of Common Stock by the Company
in a capital raising financing, provided that (a) the effective sale price per
share of Common Stock shall equal at least $0.10, (b) the transaction shall not
be a Variable Rate Transaction or MFN Transaction, and (c) the Company may issue
to the purchasers thereof, in connection with any such financing, warrants to

<PAGE>

purchase a number of shares of Common Stock equal to 50% of the number of shares
of Common Stock sold to such purchasers in such financing, provided that the
effective exercise price per share of Common Stock under such warrants shall
equal at least $0.20. For clarification, a Common Stock Financing may result
from the sale and issuance of shares of Common Stock pursuant to the exercise of
currently outstanding warrants following a reduction of the exercise price
thereunder, provided that the provisions of the preceding sentence are
satisfied.

     2. January, February, March and April Monthly Redemption. The Holder hereby
agrees that the Company, at its option, may delay payment of the interest and
Monthly Redemption Amounts due on January 1, February 1, March 1, and April 1,
2009 until May 1, 2009 (in which case on May 1, 2009 the Company shall pay the
Monthly Redemption Amounts originally due for January 1, 2009 through and
including May 1, 2009, i.e., $337,229.50, consisting of $45,289.86 principal
repayment for each of January 1, February 1, March 1, April 1 and May 1 and $
$110,780.23 of interest). The Holder at its option may at any time and from time
to time convert any or all of said $337,229.50 in principal and interest under
the Note into Common Stock of the Company at a conversion price equal to $0.10
per share.

     3. Warrants. In addition to the foregoing, the exercise price of 30% of the
Warrants held by Holder pursuant to the Transaction Documents shall be reset
from $0.375 per share to $0.20 per share.

     4. Prepayment. Notwithstanding anything contained in the Note, the Company
shall have the right to prepay the Note in cash, in whole or in part, at any
time during the Extended Waiver Period for consideration equal to the principal
amount being prepaid plus all accrued and unpaid interest thereon, provided that
(a) the Company furnishes to the Holder written notice thereof at least ten (10)
Business Days prior to the date of any such prepayment, and (b) during such
notice period the Holder may convert such principal amount elected to be
prepaid. Such prepayment amount shall be payable in full on the date selected by
the Company (which must be during the Extended Wavier Period).

     5. Rule 144. The Company acknowledges and agrees that, for purposes of Rule
144 promulgated under the Securities Act of 1933, as amended ("Securities Act"),
the holding period for the shares of Common Stock issuable upon conversion or
cashless exercise of, or otherwise pursuant to, the Note and/or Warrant, shall
have commenced on June 25, 2008 (the date of original issuance of the Note and
the Warrant), notwithstanding this Amendment. Without limiting the foregoing, if
at any time it is determined that such holding period does not relate back to
such date, the Company will promptly cause the registration of all such
underlying shares under the Securities Act (without regard to any beneficial
ownership or issuance limitations contained in the Note and/or Warrant). In
connection with any registration of shares of Common Stock pursuant to this
Section, the Company and the Holder shall enter into a registration rights
agreement containing customary and reasonable provisions regarding the
registration of securities under the Securities Act.

     6. Disclosure. To the extent the transactions contemplated by this
Amendment constitute material non-public information concerning the Company or
are otherwise required to be publicly disclosed under the Securities Exchange
Act of 1934, as amended, and the rules promulgated thereunder, the Company
shall, within three (3) business days following the date hereof, issue a press

<PAGE>

release and/or Current Report on Form 8-K disclosing the material terms of the
transactions contemplated hereby. The Company and the Holder shall consult with
each other in issuing any other press releases with respect to the transactions
contemplated hereby.

     7. Miscellaneous.
        --------------

          (a) Full Force and Effect. Except as otherwise expressly provided
     herein, each of the Purchase Agreement, the Note, the Warrant, the First
     Amendment and the other agreements and transactions contemplated thereby
     ("Transaction Documents") shall remain in full force and effect. Except for
     the waiver and modifications contained herein, this Amendment shall not in
     any way waive or prejudice any of the rights or obligations of the Holder
     or the Company under the Transaction Documents, under any law, in equity or
     otherwise, and such modifications shall not constitute a waiver or
     modification of any other provision of the Transaction Documents nor a
     waiver or modification of any subsequent default or breach of any
     obligation of the Company or of any subsequent right of the Holder.

          (b) Governing Law. This Amendment shall be governed by and construed
     in accordance with the internal laws of the State of New York.

          (c) Counterparts. This Amendment may be executed in any number of
     counterparts, each of which will be deemed an original, but all of which
     together will constitute one and the same instrument. This Amendment may be
     executed by facsimile or by email of a digital image format or portable
     document format of the signature page hereto.

     IN WITNESS WHEREOF, each of the parties hereto has caused this Amendment to
be duly executed effective the date first written above.

                                         CDEX INC.

                                         By:
                                         Name:  Malcolm H. Philips, Jr.
                                         Title: CEO
                                         Date:  February 10, 2009

                                         GEMINI MASTER FUND, LTD.
                                         By:    GEMINI STRATEGIES, LLC,
                                                as investment manager

                                         By: _______________________________
                                         Name:  Steven Winters
                                         Title: President
                                         Date:  February 10, 2009

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}]]